Home > Healthcare > Autotransfusion Devices Market

Autotransfusion Devices Market - By Product (Autotransfusion [Intraoperative, Post-operative, Dual-mode], Consumables & Accessories), Application (Cardiovascular, Orthopedic, Organ Transplantation), End-use (Hospitals, ASC) – Global Forecast, 2024 – 2032

  • Report ID: GMI8266
  • Published Date: Feb 2024
  • Report Format: PDF

Autotransfusion Devices Market Size

Autotransfusion Devices Market size was valued at around USD 514.6 million in 2023 and is anticipated to register a CAGR of 6.2% between 2024 and 2032. This robust market growth can be attributed to various factors, including ongoing advancements in technology, surging need for point-of-care testing (POCT) technologies, increasing demand for complex surgical procedures, growing demand for minimally invasive surgical techniques, and the continual growth of healthcare expenditure, among other contributing factors.

Autotransfusion Devices Market

Moreover, the global growing trend toward an aging population highlights the importance to address age-related health issues such as anaemia, coagulopathy, and surgical bleeding risk. Autotransfusion devices provide a customized strategy to blood management in the elderly, improving perioperative care and lowering the burden of transfusion-related problems in this vulnerable group.

For instance, according to a recent United Nations (UN) research, the number of people aged 65 and over globally is predicted to treble over the next three decades. The senior population is expected to reach 1.6 billion by 2050, accounting for more than 16% of the worldwide population.

Furthermore, an increasing demand for sophisticated surgical operations such as cardiovascular surgery, organ transplantation, and oncology requires the growth of suitable blood management systems. Autotransfusion systems assist in controlling intraoperative blood loss and hemostasis in difficult surgical situations, improving surgical results and patient recovery, thereby contributing to the market growth.

Autotransfusion devices are medical instruments designed to collect, process, and reinfuse a patient's own blood during surgical procedures or following significant blood loss. These devices facilitate the recovery and reuse of the patient's own blood, minimizing the need for allogeneic (donor) blood transfusions and reducing the risk of transfusion-related complications.


Autotransfusion Devices Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Factors such as continuous technological advancements in autotransfusion devices, growing trend towards miniaturization and portability, and a surging demand for integrated imaging and surgical navigation systems, among other factors are propelling the industry growth.

  • Further, there is a growing trend towards miniaturization and portability of autotransfusion devices, enabling their use in various clinical settings, including operating rooms, emergency departments, and critical care units. Compact and portable autotransfusion systems offer flexibility, convenience, and rapid deployment for intraoperative blood salvage and transfusion.
  • Moreover, integration of autotransfusion devices with surgical navigation and imaging systems enhances intraoperative visualization, precision, and safety during complex surgical procedures. Seamless integration allows surgeons to monitor blood quality, optimize transfusion parameters, and adjust treatment strategies in real time, improving patient outcomes and surgical efficiency.

Autotransfusion Devices Market Analysis

Autotransfusion Devices Market, By Product, 2021 – 2032 (USD Million)

The market by product is categorized into autotransfusion systems and consumables & accessories. The autotransfusion systems segment is further divided into intraoperative autotransfusion systems, post-operative autotransfusion systems, and dual-mode autotransfusion systems. The autotransfusion systems segment garnered USD 394.6 million revenue in 2023.

  • A growing focus on patient safety is an important driver for autotransfusion systems. Autotransfusion systems reduce the risks associated with allogeneic blood transfusions, such as transfusion responses, infectious disease transfer, and immune-mediated problems, by using the patient's own blood instead. Prioritizing patient safety is a core premise that drives the use of autotransfusion devices in surgical practice.


  • Furthermore, the autotransfusion systems enable healthcare providers to reduce reliance on allogeneic blood transfusions, which may be associated with various risks and complications. By conserving and reinfusing the patient's own blood, autotransfusion systems help minimize exposure to donor blood products, thereby enhancing transfusion safety and reducing healthcare-associated costs.


Autotransfusion Devices Market, By Application (2023)

Based on application, the autotransfusion devices market is segmented into cardiovascular surgeries, orthopedic surgeries, organ transplantations, general surgeries, and other applications. The cardiovascular surgeries segment accounted for 33.8% business share in 2023 and is anticipated to witness significant growth.

  • Cardiovascular surgeries often involve significant blood loss due to the complexity and invasiveness of the procedures. Autotransfusion devices enable blood conservation by salvaging and reinfusing the patient's own blood lost during surgery, reducing the reliance on allogeneic blood transfusions. Minimizing the need for donor blood products helps mitigate transfusion-related risks, including transfusion reactions, infections, and immunological complications.
  • Moreover, cardiovascular surgeries often require meticulous hemostasis and management of coagulation parameters to prevent bleeding complications and ensure surgical success. Autotransfusion devices allow for the efficient processing and reinfusion of the patient's own blood, which may contain clotting factors and platelets necessary for maintaining hemostasis and coagulation integrity during the perioperative period.

The autotransfusion devices market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment accounted for around USD 310.9 million revenue size in 2023.

  • Hospitals prioritize patient safety and quality improvement dual modees as fundamental components of healthcare delivery. Autotransfusion devices contribute to patient safety by reducing the risk of transfusion-related complications associated with allogeneic blood transfusions. Hospital administrators recognize the importance of implementing blood conservation strategies, including the use of autotransfusion devices, to enhance patient outcomes, minimize adverse events, and promote a culture of safety within the organization.
  • Additionally, hospitals endeavor to use advanced technology in medical equipment to improve patient care, clinical processes, and operational efficiency. Autotransfusion devices are constantly innovated and continuously developed to improve their performance, use, and safety. Hospitals that invest in cutting-edge autotransfusion technology gain access to advanced features, automation capabilities, and integrated systems that simplify intraoperative blood management, maximize resource utilization, and assist surgical teams in providing high-quality care to their patients.
North America Autotransfusion Devices Market, 2020 – 2032 (USD Million)

North America autotransfusion devices market accounted for USD 211.7 million revenue in 2023 and is predicted to witness substantial market progress.

  • North America has a highly sophisticated healthcare infrastructure, which includes cutting-edge medical facilities, technologically advanced equipment, and a well-established network of hospitals, surgery centers, and specialist clinics. The region's extensive healthcare infrastructure fosters the adoption and integration of autotransfusion devices into clinical practice, hence enabling the delivery of high-quality patient care and surgical services.

  • Furthermore, the region experiences a high volume of surgical procedures across various specialties, including cardiovascular surgery, orthopedics, trauma surgery, transplant surgery, and obstetrics. The demand for effective blood management solutions, such as autotransfusion devices, is driven by the need to minimize transfusion-related risks, optimize patient outcomes, and enhance surgical efficiency in the face of increasing surgical volumes and complexity.

Autotransfusion Devices Market Share

The autotransfusion devices industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including BECTON, DICKINSON AND COMPANY, Fresenius SE & Co. KGaA, LivaNova, Inc., Medtronic plc, Teleflex Incorporated, among others have a notable presence in the market.

Autotransfusion Devices Market Companies

Some of the eminent market participants operating in the autotransfusion devices industry include:

  • Atrium Medical Corporation
  • Becton, Dickinson, and Company
  • Beijing ZKSK Technology Co., Ltd.
  • Braile Biomédica
  • Fresenius SE & Co. KGaA
  • Gen World Medical Devices
  • Haemonetics Corporation
  • LivaNova, Inc.
  • Medtronic plc
  • Redax
  • Teleflex Incorporated

Autotransfusion Devices Industry News:

  • In March 2023, Haemonetics Corporation has announced that the US FDA (Food and Drug Administration) has granted 510(k) approval for the next-generation software for the Cell Saver Elite+ Autotransfusion System, which is now ready for full market release. This provides critical advancements in order to simplify operations, resulting in increased productivity and a better user experience.

Autotransfusion devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

  • Autotransfusion systems
    • Intraoperative autotransfusion systems
    • Post-operative autotransfusion systems
    • Dual-mode autotransfusion systems
  • Consumables & accessories

Market, By Application

  • Cardiovascular surgeries
  • Orthopedic surgeries
  • Organ transplantations
  • General surgeries
  • Other applications

Market, By End-use

  • Hospitals
  • Ambulatory surgical centers
  • Other end-users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The autotransfusion devices industry was valued at around USD 514.6 million in 2023 and is estimated to reach over USD 910.1 million by 2032, attributed to ongoing advancements in technology, surging need for point-of-care testing (POCT) technologies, increasing demand for complex surgical procedures and minimally invasive techniques.

The autotransfusion systems segment garnered USD 394.6 million in 2023 and will grow through 2032 as they reduce the risks associated with allogeneic blood transfusions, such as transfusion responses, infectious disease transfer, and immune-mediated problems.

North America autotransfusion devices industry accounted for USD 211.7 million in 2023 and is predicted to witness substantial growth through 2032 as the region has a highly sophisticated healthcare infrastructure, which includes cutting-edge medical facilities, technologically advanced equipment, and a well-established network of hospitals, surgery centers, and specialist clinics.

Atrium Medical Corporation, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomédica, Fresenius SE & Co. KGaA, Gen World Medical Devices, Haemonetics Corporation, LivaNova, Inc., Medtronic plc, Redax, and Teleflex Incorporated.

Autotransfusion Devices Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 241
  • Countries covered: 22
  • Pages: 110
 Download Free Sample